Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Becton Dickinson and Company (BDX)
Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,466,968
  • Shares Outstanding, K 284,015
  • Annual Sales, $ 18,870 M
  • Annual Income, $ 1,779 M
  • 60-Month Beta 0.55
  • Price/Sales 3.64
  • Price/Cash Flow 12.19
  • Price/Book 2.64
Trade BDX with:

Options Overview Details

View History
  • Implied Volatility 15.92% ( -0.90%)
  • Historical Volatility 19.21%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 35.45% on 10/10/22
  • IV Low 15.92% on 06/02/23
  • Put/Call Vol Ratio 0.34
  • Today's Volume 553
  • Volume Avg (30-Day) 696
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 31,184
  • Open Int (30-Day) 30,614

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 2.88
  • Number of Estimates 8
  • High Estimate 2.92
  • Low Estimate 2.82
  • Prior Year 2.66
  • Growth Rate Est. (year over year) +8.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
237.62 +5.96%
on 05/31/23
266.70 -5.59%
on 05/03/23
-12.00 (-4.55%)
since 05/02/23
3-Month
228.62 +10.14%
on 03/13/23
266.70 -5.59%
on 05/03/23
+17.83 (+7.62%)
since 03/02/23
52-Week
215.90 +16.62%
on 10/13/22
269.06 -6.42%
on 08/16/22
-1.89 (-0.75%)
since 06/02/22

Most Recent Stories

More News
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs

Intuitive Surgical (NASDAQ: ISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning

ISRG : 312.18 (+0.53%)
ABT : 104.20 (+1.34%)
BAC : 28.71 (+3.35%)
BDX : 251.79 (+1.48%)
BSX : 51.82 (+0.62%)
INTU : 430.49 (+1.98%)
JPM : 140.47 (+2.10%)
MDT : 83.76 (+1.22%)
MBOT : 1.76 (-18.52%)
SYK : 278.30 (-0.10%)
BD Advances Prefilled Flush Syringe with Integrated 'Scrub-the-Hub' Innovation

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced expanded customer availability of an...

BDX : 251.79 (+1.48%)
BD Launches World's First Spectral Cell Sorter with High-Speed Cell Imaging

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a...

BDX : 251.79 (+1.48%)
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance from the U.S....

BDX : 251.79 (+1.48%)
Health Care Collaboration in Denmark Aims to Reduce Medical Waste

/PRNewswire/ -- A new health care sector collaboration in Denmark will evaluate the feasibility of recycling used blood collection tubes to reduce medical...

BDX : 251.79 (+1.48%)
BCAL DIAGNOSTICS OPENS NEW LABORATORY IN SYDNEY AS IT ACCELERATES DEVELOPMENT OF ITS BREAST CANCER BLOOD SCREENING TOOL

/PRNewswire/ -- BCAL Diagnostics Limited (ASX:BDX) (BCAL or Company) an Australian-based biotechnology company announced the opening of its development and...

BDX : 251.79 (+1.48%)
BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised

BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal second quarter.

BDX : 251.79 (+1.48%)
ISRG : 312.18 (+0.53%)
EW : 85.34 (+0.13%)
MMSI : 84.35 (+1.76%)
Becton Dickinson (BDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall...

BDX : 251.79 (+1.48%)
Becton Dickinson (BDX) Tops Q2 Earnings and Revenue Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 4% and 3.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BDX : 251.79 (+1.48%)
HSIC : 74.42 (+1.35%)
Becton Dickinson: Fiscal Q2 Earnings Snapshot

Becton Dickinson: Fiscal Q2 Earnings Snapshot

BDX : 251.79 (+1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 257.96
2nd Resistance Point 255.73
1st Resistance Point 253.76
Last Price 251.79
1st Support Level 249.56
2nd Support Level 247.33
3rd Support Level 245.36

See More

52-Week High 269.06
Last Price 251.79
Fibonacci 61.8% 248.75
Fibonacci 50% 242.48
Fibonacci 38.2% 236.21
52-Week Low 215.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar